{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:23:39Z","timestamp":1792185819869,"version":"4.4.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.vaccine.2008.11.055","type":"journal-article","created":{"date-parts":[[2008,12,24]],"date-time":"2008-12-24T13:40:52Z","timestamp":1230126052000},"page":"I56-I61","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S8","title":["The role of complement in gonococcal infection of cervical epithelia"],"prefix":"10.1016","volume":"26","author":[{"given":"Jennifer L.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.11.055_bib1","series-title":"The human complement system in health and disease","first-page":"1","article-title":"Introduction and historical notes","author":"Frank","year":"1998"},{"key":"10.1016\/j.vaccine.2008.11.055_bib2","series-title":"The human complement system in health and disease","first-page":"9","article-title":"Overview of the complement system","author":"Volanakis","year":"1998"},{"key":"10.1016\/j.vaccine.2008.11.055_bib3","series-title":"The complement factsbook","author":"Morley","year":"2000"},{"key":"10.1016\/j.vaccine.2008.11.055_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2005.06.016","article-title":"Complement escape of human pathogenic bacteria by acquisition of complement regulators","volume":"43","author":"Kraiczy","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrmicro1824","article-title":"Complement evasion by human pathogens","volume":"6","author":"Lambris","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0162-3109(00)80300-8","article-title":"Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement","volume":"49","author":"Pangburn","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.vaccine.2008.11.055_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molimm.2006.06.011","article-title":"Bacterial complement evasion","volume":"44","author":"Rooijakkers","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib8","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.molimm.2007.06.149","article-title":"Complement evasion of pathogens: common strategies are shared by diverse organisms","volume":"44","author":"Zipfel","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib9","series-title":"Subcellular biochemistry, vol. 33. Bacterial invasion into eukaryotic cells","first-page":"61","article-title":"Host cell invasion by pathogenic Neisseriae","author":"Dehio","year":"2000"},{"key":"10.1016\/j.vaccine.2008.11.055_bib10","series-title":"Virulence mechanisms of bacterial pathogens IV","first-page":"149","article-title":"Gender differences in Neisseria gonorrhoeae pathogenesis","author":"Edwards","year":"2007"},{"key":"10.1016\/j.vaccine.2008.11.055_bib11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/CMR.17.4.965-981.2004","article-title":"The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women","volume":"17","author":"Edwards","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.11.055_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0966-842X(97)01056-1","article-title":"Adhesion and invasion by the pathogenic Neisseria","volume":"5","author":"Jerse","year":"1997","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib13","series-title":"Sexually transmitted diseases III","first-page":"451","article-title":"Gonococcal infections in the adult","author":"Hook","year":"1999"},{"key":"10.1016\/j.vaccine.2008.11.055_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1098\/rstb.1999.0431","article-title":"The transmission dynamics of gonorrhoea: modeling the reported behavior of infected patients from Newark, New Jersey","volume":"354","author":"Garnett","year":"1999","journal-title":"Phil Trans: Biol Sci"},{"key":"10.1016\/j.vaccine.2008.11.055_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJM197401172900301","article-title":"Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance","volume":"290","author":"Handsfield","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.11.055_bib16","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1128\/CMR.2.Suppl.S11","article-title":"Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae","volume":"2","author":"Densen","year":"1989","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.11.055_bib17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/IAI.38.2.563-572.1982","article-title":"Dissemination of gonococcal infection is associated with delayed stimulation of complement-dependent neutrophil chemotaxis in vitro","volume":"38","author":"Densen","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib18","series-title":"Manual of clinical microbiology","first-page":"324","article-title":"Neisseria and Branhamella","author":"Knapp","year":"1996"},{"key":"10.1016\/j.vaccine.2008.11.055_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1055\/s-2004-815595","article-title":"Sexually transmitted diseases","volume":"21","author":"Sulak","year":"2003","journal-title":"Sem Reprod Med"},{"key":"10.1016\/j.vaccine.2008.11.055_bib20","series-title":"Sexually transmitted diseases III","first-page":"433","article-title":"Biology of Neisseria gonorrhoeae","author":"Sparling","year":"1999"},{"key":"10.1016\/j.vaccine.2008.11.055_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1462-5822.2001.00140.x","article-title":"The role of complement receptor 3 (CR3) in Neisseria gonorrhoeae infection of human cervical epithelia","volume":"3","author":"Edwards","year":"2001","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1462-5822.2002.t01-1-00215.x","article-title":"A co-operative interaction between Neisseria gonorrhoeae and complement receptor 3 mediates infection of primary cervical epithelial cells","volume":"4","author":"Edwards","year":"2002","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib23","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.141.11.3902","article-title":"Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae","volume":"141","author":"Densen","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0161-5890(99)00114-5","article-title":"The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis","volume":"36","author":"Ram","year":"1999","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib25","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1128\/CMR.2.Suppl.S112","article-title":"Molecular basis for serum resistance in Neisseria gonorrhoeae","volume":"2","author":"Rice","year":"1989","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.11.055_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tim.2007.03.005","article-title":"Interactions between Neisseria meningitidis and the complement system","volume":"15","author":"Schneider","year":"2007","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1046\/j.1365-2958.1999.01469.x","article-title":"Mechanisms of neisserial serum resistance","volume":"32","author":"Vogel","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0167-5699(91)90010-Q","article-title":"Complement evasion strategies of microorganisms","volume":"12","author":"Cooper","year":"1991","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2008.11.055_bib29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2249.1995.tb03794.x","article-title":"Investigation of the complement receptor 3 (CD11b\/CD18) in human rectal epithelium","volume":"102","author":"Hussain","year":"1995","journal-title":"Clin Immunol Exp"},{"key":"10.1016\/j.vaccine.2008.11.055_bib30","series-title":"Principles and practice of infectious disease III","first-page":"1613","article-title":"Neisseria gonorrhoeae","author":"Handsfield","year":"1990"},{"key":"10.1016\/j.vaccine.2008.11.055_bib31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1083\/jcb.116.4.1007","article-title":"Generation of signals activating neutrophil functions by leukocyte integrins: LFA-1 and gp150\/95, but not CR3, are able to stimulate the respiratory burst of human neutrophils","volume":"116","author":"Berton","year":"1992","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib32","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.282.5394.1717","article-title":"Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases","volume":"282","author":"Caron","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2008.11.055_bib33","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1084\/jem.158.6.2016","article-title":"Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes","volume":"158","author":"Wright","year":"1983","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.055_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.159.2.405","article-title":"Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages","volume":"159","author":"Yamamoto","year":"1984","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.055_bib35","series-title":"The human complement system in health and disease","first-page":"167","article-title":"The complement system in reproduction","author":"Ahearn","year":"1998"},{"key":"10.1016\/j.vaccine.2008.11.055_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0015-0282(16)44117-8","article-title":"The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies","volume":"32","author":"Price","year":"1979","journal-title":"Fertil Steril"},{"key":"10.1016\/j.vaccine.2008.11.055_bib37","first-page":"145","article-title":"The complement system in reproduction","volume":"27","author":"Vanderpuye","year":"1992","journal-title":"Fertil Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib38","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/oxfordjournals.humrep.a138768","article-title":"Investigations on the cell type responsible for the endometrial secretion of complement component 3 (C3)","volume":"9","author":"Bischof","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.vaccine.2008.11.055_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0897.1993.tb00603.x","article-title":"Hormonal regulation of complement factor B in human endometrium","volume":"30","author":"Hasty","year":"1993","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0002-9378(94)70404-X","article-title":"Hormonal regulation of the complement components and receptors throughout the menstrual cycle","volume":"170","author":"Hasty","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib41","series-title":"The human complement system in health and disease","first-page":"355","article-title":"The complement system in reproduction","author":"Oglesby","year":"1998"},{"key":"10.1016\/j.vaccine.2008.11.055_bib42","first-page":"1641","article-title":"Localization of the expression of complement component 3 in the human endometrium by in situ hybridization","volume":"81","author":"Sayegh","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.vaccine.2008.11.055_bib43","series-title":"Principles and practice of infectious disease V","first-page":"67","article-title":"Complement","author":"Densen","year":"2000"},{"key":"10.1016\/j.vaccine.2008.11.055_bib44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0966-842X(00)88921-0","article-title":"Recognition and control of neisserial infection by antibody and complement","volume":"3","author":"Jarvis","year":"1995","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1286-4579(99)80063-X","article-title":"Role of complement in host defense against bacterial infection","volume":"1","author":"Mold","year":"1999","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2008.11.055_bib46","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.4049\/jimmunol.124.5.2105","article-title":"Natural serum bactericidal activity against Neisseria gonorrhoeae isolates from disseminated, locally invasive, and uncomplicated disease","volume":"124","author":"Rice","year":"1980","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib47","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1128\/IAI.73.7.4171-4179.2005","article-title":"Neisseria gonorrhoeae kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-expressing human B cells and inhibits antibody production","volume":"73","author":"Pantelic","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib48","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1128\/IAI.67.8.3937-3946.1999","article-title":"Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections","volume":"67","author":"Hedges","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib49","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1128\/IAI.62.5.1755-1760.1994","article-title":"Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae","volume":"62","author":"Jarvis","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/314545","article-title":"Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects","volume":"179","author":"McQuillen","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.055_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1172\/JCI110589","article-title":"Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins","volume":"70","author":"Rice","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2008.11.055_bib52","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1462-5822.2002.00212.x","article-title":"The role of lipooligosaccharide in Neisseria gonorrhoeae pathogenesis of cervical epithelia: lipid A serves as a C3 acceptor molecule","volume":"4","author":"Edwards","year":"2002","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib53","doi-asserted-by":"crossref","first-page":"50853","DOI":"10.1074\/jbc.M308364200","article-title":"Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity","volume":"278","author":"Ram","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2008.11.055_bib54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1128\/IAI.00613-07","article-title":"Defining targets for complement components C4b and C3b on the pathogenic Neisseriae","volume":"76","author":"Lewis","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib55","series-title":"Fundamental immunology","first-page":"645","article-title":"Complement","author":"Brown","year":"1984"},{"key":"10.1016\/j.vaccine.2008.11.055_bib56","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1073\/pnas.74.7.2701","article-title":"Interaction between the third complement protein and cell surface macromolecules","volume":"74","author":"Law","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.11.055_bib57","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.4049\/jimmunol.160.8.4057","article-title":"Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaMbeta2 (CD11b\/CD18)","volume":"160","author":"DiScipio","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib58","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1128\/IAI.68.9.5354-5363.2000","article-title":"Neisseria gonorrhoeae elicits membrane ruffling and cytoskeletal rearrangements upon infection of primary human endocervical and ectocervical cells","volume":"68","author":"Edwards","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2958.2006.05478.x","article-title":"Characterization of the OxyR regulon of N. gonorrhoeae","volume":"63","author":"Seib","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib60","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1128\/IAI.73.12.8444-8448.2005","article-title":"Azurin of pathogenic Neisseria is involved in defense against hydrogen peroxide and survival within cervical epithelial cells","volume":"73","author":"Wu","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2958.2006.05079.x","article-title":"The PerR regulon controls Mn-dependent resistance to oxidative stress in Neisseria gonorrhoeae","volume":"60","author":"Wu","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/infdis\/136.2.248","article-title":"Ultrastructure study of cervical gonorrhea","volume":"136","author":"Evans","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.055_bib63","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/IAI.73.4.1964-1970.2005","article-title":"Biofilm formation by Neisseria gonorrhoeae","volume":"73","author":"Greiner","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib64","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1462-5822.2006.00707.x","article-title":"Gonococcal PLD directly interacts with Akt kinase upon infection of primary human cervical epithelial cells","volume":"8","author":"Edwards","year":"2006","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib65","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/IAI.71.11.6381-6391.2003","article-title":"Gonococcal phospholipase D modulates the expression and function of complement receptor 3 in primary cervical epithelial cells","volume":"71","author":"Edwards","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib66","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1093\/emboj\/18.18.4915","article-title":"A tyrosine-based sorting signal in the \u03b22 integrin cytoplasmic domain mediates its recycling to the plasma membrane and is required for ligand-supported migration","volume":"18","author":"Fabbri","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2008.11.055_bib67","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1091\/mbc.E05-05-0413","article-title":"Dynamic partitioning into lipid rafts controls the endo\u2013exocytic cycle of the \u03b1L\/\u03b22 integrin, LFA-1, during leukocyte chemotaxis","volume":"16","author":"Fabbri","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.vaccine.2008.11.055_bib68","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.bi.57.070188.001541","article-title":"Molecular organization of the complement system","volume":"57","author":"M\u00fcller-Eberhard","year":"1988","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.vaccine.2008.11.055_bib69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1084\/jem.146.1.257","article-title":"Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein b1H for cleavage of C3b and C4b in solution","volume":"146","author":"Pangburn","year":"1977","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.055_bib70","series-title":"The human complement system in health and disease","first-page":"49","article-title":"Complement enzymes","author":"Volanakis","year":"1998"},{"key":"10.1016\/j.vaccine.2008.11.055_bib71","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/infdis\/157.4.697","article-title":"Analysis of C3 deposition and degradation on bacterial surfaces after opsonization","volume":"157","author":"Gordon","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.055_bib72","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1084\/jem.161.6.1414","article-title":"Deposition of C3b and iC3b onto particulate activators of the human complement system","volume":"161","author":"Newman","year":"1985","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.055_bib73","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.4049\/jimmunol.131.4.1930","article-title":"C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface","volume":"131","author":"Pangburn","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4049\/jimmunol.122.1.75","article-title":"Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and b1H for cell-bound C3b","volume":"122","author":"Kazatchkine","year":"1979","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib75","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1128\/IAI.60.10.4439-4442.1992","article-title":"Effect of exogenous sialylation on Neisseria gonorrhoeae on opsonophagocytosis","volume":"60","author":"Kim","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib76","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0882-4010(88)90103-9","article-title":"Cytidine 5\u2032-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum","volume":"5","author":"Parsons","year":"1988","journal-title":"Microb Pathogenesis"},{"key":"10.1016\/j.vaccine.2008.11.055_bib77","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1099\/13500872-141-4-913","article-title":"Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens","volume":"141","author":"de la Paz","year":"1995","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2008.11.055_bib78","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1084\/jem.187.5.743","article-title":"A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae","volume":"187","author":"Ram","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.055_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1128\/IAI.60.1.39-43.1992","article-title":"Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera","volume":"60","author":"Wetzler","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib80","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1128\/IAI.73.11.7390-7397.2005","article-title":"Enhanced factor H binding to sialylated gonococci is restricted to the sialylated lacto-N-neotetrose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in gonococci","volume":"73","author":"Gulati","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib81","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1084\/jem.188.4.671","article-title":"Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae","volume":"188","author":"Ram","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.055_bib82","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.4049\/jimmunol.178.7.4489","article-title":"Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin","volume":"178","author":"Madico","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib83","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1567-5769(00)00037-0","article-title":"C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae","volume":"1","author":"Ram","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib84","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.4049\/jimmunol.166.11.6764","article-title":"A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4B-binding protein","volume":"166","author":"Blom","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib85","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.4049\/jimmunol.130.4.1867","article-title":"Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen","volume":"130","author":"Liang-Takasaki","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib86","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/IAI.41.2.563-569.1983","article-title":"Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of Salmonellae","volume":"41","author":"Liang-Takasaki","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib87","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/IAI.54.3.689-694.1986","article-title":"Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeuruginosa","volume":"54","author":"Schiller","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib88","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4049\/jimmunol.139.4.1253","article-title":"C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae","volume":"139","author":"Jimenez-Lucho","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib89","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4049\/jimmunol.118.1.362","article-title":"Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharide (LPS)","volume":"118","author":"Morrison","year":"1977","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib90","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/IAI.66.2.399-405.1998","article-title":"Complementary recognition of alternative pathway activators by decay-accelerating factor and factor H","volume":"66","author":"Kraus","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib91","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0161-5890(87)90173-8","article-title":"Activation of human serum complement by bacterial lipopolysaccharides: structural requirements for antibody independent activation of the classical and alternative pathways","volume":"24","author":"Vukajlovich","year":"1987","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib92","first-page":"2420","article-title":"The mimicry of human glycolipids and glycosphingolipids in the lipooligosaccharides of pathogenic Neisseria and Haemophilus","volume":"65","author":"Harvey","year":"2001","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib93","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1128\/IAI.60.7.3017-3020.1992","article-title":"Further antigenic similarities of Neisseria gonorrhoeae lipooligosaccharides and human glycosphingolipids","volume":"60","author":"Mandrell","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib94","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0171-2985(11)80352-9","article-title":"Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS","volume":"187","author":"Mandrell","year":"1993","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2008.11.055_bib95","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1084\/jem.168.1.107","article-title":"Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens","volume":"168","author":"Mandrell","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.055_bib96","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1574-695X.1996.tb00127.x","article-title":"Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease","volume":"16","author":"Moran","year":"1996","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib97","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2958.1997.4841857.x","article-title":"Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria","volume":"25","author":"K\u00e4llstr\u00f6m","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib98","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1462-5822.2005.00547.x","article-title":"I-domain-containing integrins serve as pilus receptors for Neisseria gonorrhoeae adherence to human epithelial cells","volume":"7","author":"Edwards","year":"2005","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib99","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1084\/jem.20031159","article-title":"Down-regulation of CD46 by piliated Neisseria gonorrhoeae","volume":"198","author":"Gill","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.055_bib100","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1128\/IAI.73.5.3072-3082.2005","article-title":"CD46-independent binding of neisserial type IV pili and the major pilus adhesin, PilC, to human epithelial cells","volume":"73","author":"Kirchner","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.055_bib101","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1099\/00221287-147-8-2333","article-title":"Inverse relationship between pilus-mediated gonococcal adherence and surface expression of the pilus receptor, CD46","volume":"147","author":"Tobiason","year":"2001","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2008.11.055_bib102","first-page":"1455","article-title":"Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease","volume":"151","author":"Simpson","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2008.11.055_bib103","doi-asserted-by":"crossref","first-page":"19979","DOI":"10.1074\/jbc.274.28.19979","article-title":"Importance of the carboxyl-terminal FTSL motif of membrane cofactor protein for basolateral sorting and endocytosis. Positive and negative modulation by signals inside and outside the cytoplasmic tail","volume":"274","author":"Teuchert","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2008.11.055_bib104","doi-asserted-by":"crossref","first-page":"20793","DOI":"10.1074\/jbc.272.33.20793","article-title":"Membrane cofactor protein (CD46) is a basolateral protein that is not endocytosed. Importance of the tetrapeptide FTSL at the carboxyl terminus","volume":"272","author":"Maisner","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2008.11.055_bib105","doi-asserted-by":"crossref","first-page":"18853","DOI":"10.1074\/jbc.271.31.18853","article-title":"Two different cytoplasmic tails direct isoforms of the membrane cofactor protein (CD46) to the basolateral surface of Madin\u2013Darby canine kidney cells","volume":"271","author":"Maisner","year":"1996","journal-title":"J Biol Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T05:14:15Z","timestamp":1684818855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08016022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":105,"alternative-id":["S0264410X08016022"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}